Kathleen Joy Propert

faculty photo
Professor of Biostatistics in Biostatistics and Epidemiology at the Hospital of the University of Pennsylvania
Member, Graduate Group in Epidemiology and Biostatistics (GGEB),University of Pennsylvania Perelman School of Medicine
Senior Scholar, Center for Clinical Epidemiology and Biostatistics (CCEB), University of Pennsylvania Perelman School of Medicine
Member, Institute for Translational Medicine and Therapeutics (ITMAT), University of Pennsylvania Perelman School of Medicine
Director, Biostatistics Core, Institute for Translational Medicine and Therapeutics (ITMAT), University of Pennsylvania Perelman School of Medicine
Director of Biostatistics, Integrative Health Sciences Facility Core,Center for Excellence in Environmental Toxicology(CEET), University of Pennsylvania
Department: Biostatistics and Epidemiology

Contact information
Department of Biostatistics and Epidemiology
University of Pennsylvania Perelman School of Medicine
614 Blockley Hall, 423 Guardian Drive
Philadelphia, PA 19104-6021
Office: 215-746-8603
Fax: 215-573-4865
Graduate Group Affiliations
Education:
B.S. (Applied Biological Sciences)
Massachusetts Institute of Technology, Cambridge, MA, 1982.
M.S. (Biostatistics)
Harvard School of Public Health, Boston, MA, 1984.
Sc.D. (Biostatistics)
Harvard School of Public Health, Boston, MA, 1990.
Permanent link
 

Description of Itmat Expertise

Dr. Propert directs the Study Design and Biostatistics (SDAB) Core for ITMAT. Her methodological research focus is on optimal study design, particularly for T1 translational research in animal models and early stage clinical trials. Her current clinical areas of focus are traumatic brain injury, lipid metabolism, and pulmonary disease.

Selected Publications

Sekiguchi DR, Sutter JA, Rickels MR, Naji A, Liu C, Propert KJ, Rogers WT, Luning Prak ET: Analysis of B cell subsets following pancreatic islet cell transplantation in a patient with type 1 diabetes by cytometric fingerprinting. Journal of Immunological Methods 363(2): 233-44, Jan 2011.

Dibble CT, Lima JAC, Bluemke DA, Chirinos JA, Chahal H, Bristow MR, Kronmal RA, Barr RG, Ferrari VA, Propert KJ, Kawut SM: Regional left ventricular systolic function and the right ventricle: the MESA-right ventricle study. Chest 140(2): 310-6, Aug 2011.

Sekiguchi DR, Smith SB, Sutter JA, Goodman NG, Propert K, Louzoun Y, Rogers W, Luning Prak ET: Circulating lymphocyte subsets in normal adults are variable and can be clustered into subgroups. Cytometry. Part B, Clinical Cytometry 80B(5): 291-99, Sep 2011.

Hsu C, Propert K, Xie D, Hamm L, He J, Miller E, Ojo A, Shlipak M, Teal V, Townsend R, Weir M, Wilson J, Feldman H, for the CRIC Investigators: Measured GFR does not outperform estimated GFR in predicting CKD-related complications. Journal of the American Society of Nephrology: JASN 22(10): 1931-37, Oct 2011.

Jain V, Abdulmalik O, Propert KJ, Wehrli FW: Investigating the magnetic susceptibility properties of fresh human blood for noninvasive oxygen saturation quantification. Magnetic Resonance in Medicine 68(3): 863-7, Dec 2011.

Zhang H, Qiao H, Frank RS, Huang B, Propert KJ, Margulies S, Ferrari VA, Epstein JA, Zhou R: Spin labeling-MRI detects increased myocardial blood flow post endothelial cell transplantation in the infarcted heart. Circulation, Cardiovascular Imaging 5(2): 210-7, Mar 2012.

Fitzgerald MP, Payne CK, Lukacz ES, Yang CC, Peters KM, Chai TC, Nickel JC, Hanno PM, Kreder KJ, Burks DA, Mayer R, Kotarinos R, Fortman C, Allen TM, Fraser L, Mason-Cover M, Furey C, Odabachian L, Sanfield A, Chu J, Huestis K, Tata GE, Dugan N, Sheth H, Bewyer K, Anaeme A, Newton K, Featherstone W, Halle-Podell R, Cen L, Landis JR, Propert KJ, Foster HE Jr, Kusek JW, Nyberg LM; Interstitial Cystitis Collaborative Research Network: Randomized multicenter clinical trial of myofascial physical therapy in women with interstitial cystitis/painful bladder syndrome and pelvic floor tenderness. The Journal of Urology 187(6): 2113-8, April 2012.

Skarke C, Alamuddin N, Lawson JA, Cen L, Propert KJ, Fitzgerald GA: Comparative impact on prostanoid biosynthesis of celecoxib and the novel nonsteroidal anti-inflammatory drug CG100649. Clinical Pharmacology & Therapeutics 91(6): 986-93, June 2012.

Lunardon L, Tsai KJ, Propert KJ, Fett N, Stanley JR, Werth VP, Tsai DE, Payne AS: Adjuvant rituximab therapy of pemphigus: a single center experience with 31 patients. Archives of Dermatology 148(9): 1031-6, Sep 2012

back to top
Last updated: 12/05/2014
The Trustees of the University of Pennsylvania